[HTML][HTML] A review of heterogeneity in attention deficit/hyperactivity disorder (ADHD)
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects
approximately 8%-12% of children worldwide. Throughout an individual's lifetime, ADHD …
approximately 8%-12% of children worldwide. Throughout an individual's lifetime, ADHD …
ADHD and anxiety: clinical significance and treatment implications
FW Reimherr, BK Marchant, TE Gift… - Current Psychiatry …, 2017 - Springer
In comparison to the DSM formulation of ADHD, we have proposed that ADHD in adults
should be divided into Inattentive and Emotional Dysregulation Presentations. Under both …
should be divided into Inattentive and Emotional Dysregulation Presentations. Under both …
Persistence and remission of ADHD during adulthood: a 7-year clinical follow-up study
BackgroundCourse and predictors of persistence of attention deficit hyperactivity disorder
(ADHD) in adults are still largely unknown. Neurobiological and clinical differences between …
(ADHD) in adults are still largely unknown. Neurobiological and clinical differences between …
Prediction of drop-out and outcome in integrated cognitive behavioral therapy for ADHD and SUD: Results from a randomized clinical trial
K van Emmerik-van Oortmerssen, M Blankers… - Addictive …, 2020 - Elsevier
Background Patients with substance use disorder (SUD) or Attention Deficit Hyperactivity
Disorder (ADHD) have a high risk of drop out from treatment. Few studies have investigated …
Disorder (ADHD) have a high risk of drop out from treatment. Few studies have investigated …
No significant association between genetic variants in 7 candidate genes and response to methylphenidate treatment in adult patients with ADHD
V Contini, MM Victor, GP Bertuzzi… - Journal of clinical …, 2012 - journals.lww.com
Results from pharmacogenetic investigations of methylphenidate (MPH) response in
patients with ADHD are still inconsistent, especially among adults. This study investigates …
patients with ADHD are still inconsistent, especially among adults. This study investigates …
Pharmacogenetics of response to methylphenidate in adult patients with attention-deficit/hyperactivity disorder (ADHD): a systematic review
Methylphenidate (MPH) is a first line option in the psychopharmacologic treatment of adults
with Attention-Deficit/Hyperactivity Disorder (ADHD). However, there is a considerable …
with Attention-Deficit/Hyperactivity Disorder (ADHD). However, there is a considerable …
Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD
V Contini, MM Victor, FZC Marques, GP Bertuzzi… - Journal of neural …, 2010 - Springer
Several lines of evidence suggest a relevant role for the dopamine transporter (DAT1) gene
not only as a susceptibility factor for attention-deficit hyperactivity disorder (ADHD), but also …
not only as a susceptibility factor for attention-deficit hyperactivity disorder (ADHD), but also …
Exocytosis-related genes and response to methylphenidate treatment in adults with ADHD
BS Da Silva, RB Cupertino, DL Rovaris… - Molecular …, 2018 - nature.com
Experimental studies have demonstrated that methylphenidate (MPH) modulates the
synaptic vesicle trafficking and synaptotagmin-1 (SytI) mRNA levels. SytI is a regulatory …
synaptic vesicle trafficking and synaptotagmin-1 (SytI) mRNA levels. SytI is a regulatory …
Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD
V Contini, MM Victor, CCS Cerqueira, ER Polina… - European archives of …, 2011 - Springer
Adrenergic α2A receptor gene (ADRA2A) is one of the most promising candidate genes for
ADHD pharmacogenetics. Thus far, three studies have investigated the association between …
ADHD pharmacogenetics. Thus far, three studies have investigated the association between …
Treatment dropout and missed appointments among adults with attention-deficit/hyperactivity disorder: associations with patient-and disorder-related factors
HM Soendergaard, PH Thomsen… - The Journal of clinical …, 2016 - psychiatrist.com
Objective: Knowledge of factors associated with treatment dropout and missed appointments
in adults with attention-deficit/hyperactivity disorder (ADHD) is very limited. On the basis of …
in adults with attention-deficit/hyperactivity disorder (ADHD) is very limited. On the basis of …